FFO
ORIC icon

Fortitude Family Office’s Oric Pharmaceuticals ORIC Stock Holding History

Fortitude Family Office’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.4K Buy
+314
New +$2.85K ﹤0.01% 1257
2025
Q2 		– Sell
-607
Closed -$3.39K – 2101
2025
Q1 		$3.39K Buy
607
+33
+6% +$289 ﹤0.01% 824
2024
Q4 		$4.63K Hold
574
– – ﹤0.01% 866
2024
Q3 		$5.88K Hold
574
– – ﹤0.01% 735
2024
Q2 		$4.06K Hold
574
– – ﹤0.01% 666
2024
Q1 		$7.89K Hold
574
– – 0.01% 451
2023
Q4 		$5.28K Buy
+574
New +$4.15K ﹤0.01% 603

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fortitude Family Office's ORIC Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Oric Pharmaceuticals (ORIC) in Q2 2026: 314 shares worth $3.4K. The stake represents ﹤0.01% of the portfolio and ranks #1257 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in ORIC as recently as Q1 2025.

Fortitude Family Office first reported a position in ORIC in Q4 2023 and has held it in 7 quarters since. The position peaked at $7.89K in Q1 2024. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Fortitude Family Office held 314 shares of Oric Pharmaceuticals worth $3.4K as of Q2 2026.
  • Oric Pharmaceuticals was a new Fortitude Family Office position in Q2 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1257 holding.
  • Fortitude Family Office first reported a position in Oric Pharmaceuticals in Q4 2023 and has held it in 7 quarters since.
  • Fortitude Family Office's Oric Pharmaceuticals position peaked at $7.89K in Q1 2024.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.